The Evaluation of Dermoscopic Findings in Basal Cell Carcinoma
نویسندگان
چکیده
Introduction: Many surface microscopy features of pigmented BCCs have been described. The purpose of this study was to review dermoscopic findings of BCC and to investigate their incidence in different dermatopathological subtypes. Material and Methods: Dermoscopic examination of 130 skin lesions in 113 patients with the preliminary diagnosis of BCC, without knowledge of the dermatopathological diagnosis was performed. For all lesions, macroscopic clinical photographs and documentation of the dermoscopic findings were performed. Routine biopsy procedures were carried out and haematoxylin and eosin stained sections were examined for dermatopathologic diagnosis and evalulation of dermatopathologic subtypes. Results: Preoperative diagnostic accuracy rate of dermoscopy in the diagnosis of BCC was found to be 95.3%. A total of 14 morphological dermoscopic criteria were identified. The most common dermoscopic finding was vascular structures (87.7%) with arborising vessels (78%). Vascular structures and ulceration were observed in all dermatopathological subtypes but except fibrosing BCC. Blue globules, mapple leaf like pattern, blue-gray ovoid nests and blue-grey areas were more commonly seen in pigmented BCC. Comedo like openings without a collision of seborrheic keratosis was observed in 3,2% of the BCCs which was not reported in association with BCC, previously. Conclusions: In our study dermoscopy maintained 95.3% preoperative diagnostic accuracy rate in BCC. In this way dermoscopy hinders unnecessary surgical procedures which might be carried out. Our study indicated that the six morphological findings that had already been reported for pigmented BCC can be seen in other dermatopathologic subtypes as well.
منابع مشابه
Evaluation of Immunohistochemical Findings and Clinical Features associated with Local Aggressiveness in Basal Cell Carcinoma
Background & Objective:Basal cell carcinoma (BCC) is classified into BCC1 or low risk (nodular, superficial type) and BCC2 or high risk (micronodular, morpheaform, infiltrative, and basosquamous types) based on clinical behavior. This study attempts to evaluate immunohistochemical (IHC) findings and clinical features associated with local aggressiveness and recurrence ...
متن کاملEvaluation of Diagnostic Values of EMA and Ber-Ep4 in Distinction between Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin
Background and Objective: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are two common tumors of the skin. In some cases, distinction between BCC and SCC can be difficult. This study aimed to clarify this uncertainty through immunohistochemical analysis. In this respect, epithelial membran...
متن کاملEvaluation of the Primary Response of Basal Cell Carcinoma to Aminolevulinic Acid Photodynamic Therapy
Background: Basal Cell Carcinoma (BCC) is the most common type of skin cancer in human beings. Photodynamic therapy (PDT) is a novel therapeutic method which may be regarded as a non-invasive useful alternative for traditional treatments of BCC. This study was designed with the aim of evaluating the primary response of BCC to PDT.Methods: This clinical trial was perform...
متن کاملThe Usefulness of CD10 in Distinguishing between Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
Background & Objectives: CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical studies have assessed CD10 expression in cutaneous epithelial neoplasms. Our goal was to d...
متن کاملComparison of COX2 expression in radiation induced basal cell carcinoma and non-radiation induced basal cell carcinoma
Background: Radiation-induced basal cell carcinoma (BCC) can be multiple, large, and recurring, which complicates its treatment in some cases. According to reports on the role of cyclooxygenase 2 (COX2) inhibitors in the treatment or prevention of non-melanoma skin cancers and considering the fact that COX2 expression has not been evaluated in radiation-in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010